Sodium phosphate dihydrate

To be reconstituted with sterile WFI (pH approximately 7.2) Per lOmL 500 mg sucrose 0.5 mg polysorbate 80 2.2 mg monobasic sodium phosphate monohydrate 6.1 mg dibasic sodium phosphate dihydrate IV infusion... 

Anhydrous dibasic sodium phosphate [7558-79-4] Dibasic sodium phosphate dihydrate [10028-24-7] Dibasic sodium phosphate dodecahydrate [10039-32-4] Dibasic sodium phosphate heptahydrate [7782-85-6] Dibasic sodium phosphate hydrate [10140-65-5] Dibasic sodium phosphate monohydrate [118830-14-1]... 

One gram of dibasic sodium phosphate dihydrate represents approximately 11.2 mmol of sodium and 5.6mmol of phosphate. 

Anhydrous monobasic sodium phosphate [7558-80-7] Monobasic sodium phosphate monohydrate [10049-21-5] Monobasic sodium phosphate dihydrate [13472-35-0]... 

One gram of monobasic sodium phosphate dihydrate represents approximately 6.4 mmol of sodium and of phosphate. 

Each syringe deiivers 0.8 ml (40 mg) of DP. Each vial contains approximately 0.9 mL of solution to deiiver 0.8 ml (40 mg) of DP. Each 0.8 ml contains 40 mg of adaiimumab, 4.93 mg of sodium chioride, 0.69 mg of monobasic sodium phosphate dihydrate, 1.22 mg of dibasic sodium phosphate dihydrate, 0.24 mg of sodium citrate, 1.04 mg of citric acid monohydrate, 9.6 mg of mannitol, 0.8 mg of polysorbate 80 and water for injection, USP. Sodium hydroxide added as necessary to adjust pH. 

Each vial contains either 74, 118.4, 177.6, or 222 p.g of PEG-intron, and 1.11 mg of dibasic sodium phosphate anhydrous, 1.11 mg of monobasic sodium phosphate dihydrate, 59.2 mg of sucrose, and 0.074 mg of polysorbate 80. Following reconstitution with 0.7 mL of the supplied diluent (SWFI, USP), each vial contains peginterferon at strengths of either 100, 160, 240, or 300 p,g/mL. 

Dibasic sodium phosphate. See Sodium phosphate dibasic anhydrous Dibasic sodium phosphate dihydrate. See Sodium phosphate dibasic dihydrate Dibasic sodium phosphate dodecahydrate. See Sodium phosphate dibasic dodecahydrate Dibasic sodium phosphate heptahydrate. See Sodium phosphate dibasic heptahydrate Dibasic zinc stearate. See Zinc stearate... 

Synonyms Dibasic sodium phosphate dihydrate Disodium hydrogen phosphate dihydrate Disodium monohydrogen orthophosphate Disodium orthophosphate Disodium phosphate dihydrate DSP-2 s-Sodium phosphate dihydrate Ciassification inorganic sait Definition Phosphoric acid, disodium sait Empiricai HNa204P 2H20 Formuia Na2HP04 2H20... 

Manuf./Distrib. AMRESCO Aldrich EMD Chems. FMC Lohmann Mallinckrodt Baker Monsanto Rhodia Ruger Sigma-Aldrich Chemie GmbH/Fluka Sigma Spectrum Chems. Lab. Prods. Voigt Global Distrib. s-Sodium phosphate dihydrate. See Sodium phosphate dibasic dihydrate s-Sodium phosphate dodecahydrate. See Sodium phosphate dibasic dodecahydrate... 

An abrasive is usually chemically inert, neither interacting with other dentifrice ingredients nor dissolving in the paste or the mouth. Substances used as dentifrice abrasives include amorphous hydrated silica, dicalcium phosphate dihydrate [7789-77-7] anhydrous dicalcium phosphate [7757-93-9] insoluble sodium metaphosphate [10361-03-2], calcium pyrophosphate [35405-51-7], a-alumina trihydrate, and calcium carbonate [471-34-1]. These materials are usually synthesized to specifications for purity, particle size, and other characteristics naturally occurring minerals are used infrequently. Sodium bicarbonate [144-55-8] and sodium chloride [7647-14-5] have also been employed as dentifrice abrasives. 

Dissolve 3.6 g di-sodium hydrogen phosphate dihydrate in 100 ml water and adjust the pH to 7.5 with phosphoric acid. Dissolve 2.5 g taurine in this. 

C9H11N307P-,Na+,2 H20 Sodium cytidine 2, 3 -cyclic phosphate, dihydrate (CYTCYP20)285... 

C9HUN307P- Na+ 2 H20 Cytidine (sodium 2, 3 -phosphate), dihydrate CYTCYP20 43 357... 

Monocalcium phosphate monohydrate reacts almost as quickly as cream of tartar (potassium acid tartrate). Anhydrous monocalcium phosphate has four-fifths of the reactivity. At ambient temperatures dicalcium phosphate dihydrate, sodium aluminium phosphate and some grades of sodium acid pyrophosphate are essentially unreactive. 

Avastin Avastin is used for the treatment of colorectal cancer. It is supplied in 100 and 400 mg dosages. The 100 mg formulation consists of 240 mg a,a-trehalose dihydrate, 23.2 mg sodium phosphate (monobasic, monohydrate), 4.8mg sodium phosphate (dibasic, anhydrous), 1.6mg polysorbate 20 and water-for-injection. 

PEG-Intron PEG-Intron is used for the treatment of hepatitis C. The product consists of a covalent conjugate of the recombinant interferon- -2b with monomethoxy polyethylene glycol (PEG) supplied in vials with 74/rg, 118.4/rg, 177.6/rg, or 222/rg of the active ingredient and 1.11 mg sodium phosphate (dibasic,anhydrous),l.ll mg sodium phosphate (monobasic, dihydrate), 59.2 mg sucrose, and 0.074mg polysorbate 80. The powder is reconstituted with sterile water-for-injection. 

Disodium hydrogen phosphate dihydrate (25.5 g), potassium dihydrogen phosphate (9.0 g), ammonium chloride (1.0 g) and sodium chloride (0.5 g) were dissolved in water and the volume adjusted to 900 mL. The solution was sterilized by autoclaving (121 °C, 20 min) and allowed to cool to room temperature. Magnesium sulfate (240.5 mg), kanamycin (50 mg), thiamine (10 mg) and glucose (5 g) were dissolved in water and adjusted to 100 mL volume. This mixture was sterilized by filtration through a 0.2 pm filter and added to the salt solution. 

Ammonium chloride buffer, pFH 7.5 - dissolve 400 g ammonium chloride (NH4CI), 40 g EDTA disodium salt, 40 g sodium dihydrogen phosphate dihydrate (NaH2P04.2FH20) and 0.08 g copper sulphate pentahydrate (CUSO4.5H2O) in 1400 ml previously heated water (5 min in a domestic microwave) contained in a 3-1 beaker. Adjust the pFH to 7.5 0.1 with 10% w/v NaOH and make up to 2 I. 

Sodium diphosphate is prepared by the following procedure. Disodium hydrogen phosphate dihydrate, Na2HP04 2H20, (7.12 g, 40 mmole) is placed in a 60-mL platinum crucible and heated in air at 400° for 12 hours (Product Merck for analysis K 6580). According to Porthault,2 this method leads to a tetrasodium diphosphate, Na4P207, the purity of which is better than 99.5%. No impurities can be found by chromatographic or potentiometric analysis. 

Tablets were prepared either with an insoluble (dicalcium phosphate dihydrate), a soluble (6-lactose) or a moderately soluble filler-binder (a-lactose monohydrate). As a disintegrant four different starches (com, rice, potato and tapioca) were used. As a comparison the effect of two super-disintegrants (crospovidone and sodium starch glycolate) was studied. The disintegrants were added at two concentration levels. The compression load was adjusted in order to obtain tablets with comparable initial cmshing strengths.

Pre filled syringe polysorbate-80 containing (HSA- free) formulation glycine polysorbate 80 sodium chloride sodium phosphate monobasic dihydrate sodium phosphate dibasic dihydrate water for injection... 

---